Unknown PHASE1/PHASE2 INTERVENTIONAL NCT01315977

Dietary Antioxidants, Redox Tone and Health Promotion: an Orthomolecular Study of Interactions

Orthomolecular Mechanisms of Health Effects of Antioxidant Rich Diets, With Focus on Green Tea (Camellia Sinensis), DNA Protection and Key Biochemical Products/Effects of the Antioxidant Response Element

Sponsor: Our Lady of Maryknoll Hospital

Conditions Type 2 Diabetes Mellitus

Interventions Green tea

Updated 5 times since 2017 Last updated: Mar 15, 2011 Started: Feb 28, 2011 Primary completion: Feb 29, 2012 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Type 2 Diabetes Mellitus and is currently ongoing. Our Lady of Maryknoll Hospital leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Our Lady of Maryknoll Hospital
The Hong Kong Polytechnic University

Data source: The Hong Kong Polytechnic University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kowloon, China